90
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Effect of sub-chronic ferrous sulfate treatment on motor skills, hematological and biochemical parameters in rats

, , , &
Pages 179-184 | Received 21 Apr 2017, Accepted 17 Oct 2017, Published online: 27 Nov 2017

References

  • Bothwell TH. Overview and mechanisms of iron regulation. Nutr Rev. 1995;53:237–245. doi:10.1111/j.1753-4887.1995.tb05480.x. PMID:8577406.
  • Lonnerdal B. Iron Metabolism in Infants. Boca Ration, FL: CRC Press, Inc; 1989:163.
  • Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285–297. doi:10.1016/S0092-8674(04)00343-5. PMID:15109490.
  • Aquino Jde S, Tavares RL, Medeiros Lde B, Martins CC, Pessoa DC, Stamford TL. Effect of the consumption on buriti oil on the metabolism of rats induced by iron overload. Arch Endocrinol Metab. 2015;59:422–427. doi:10.1590/2359-3997000000105. PMID:26421670.
  • Chacko J, Pennell DJ, Tanner MA, et al. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Br J Haematol. 2007;138:587–593. doi:10.1111/j.1365-2141.2007.06695.x. PMID:17610536.
  • Chen W, Paradkar PN, Li L, et al. Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria. Proc Natl Acad Sci U S A. 2009;106:16263–16268. doi:10.1073/pnas.0904519106. PMID:19805291.
  • Maaroufi K, Ammari M, Elferchichi M, et al. Effects of combined ferrous sulphate administration and exposure to static magnetic field on spatial learning and motor abilities in rats. Brain Inj. 2013;27:492–499. doi:10.3109/02699052.2012.750753. PMID:23473426.
  • Maaroufi K, Ammari M, Jeljeli M, Roy V, Sakly M, Abdelmelek H. Impairment of emotional behavior and spatial learning in adult Wistar rats by ferrous sulfate. Physiol Behav. 2009;96:343–349. doi:10.1016/j.physbeh.2008.10.019.
  • Maaroufi K, Save E, Poucet B, Sakly M, Abdelmelek H, Had-Aissouni L. Oxidative stress and prevention of the adaptive response to chronic iron overload in the brain of young adult rats exposed to a 150 kilohertz electromagnetic field. Neuroscience. 2011;186:39–47. doi:10.1016/j.neuroscience.2011.04.003. PMID:21497179.
  • Shidfar F, Amani S, Vafa M, et al. Effects of iron supplementation with and without docosahexaenoic acid on the cardiovascular disease risk based on paraoxonase-1, hs-CRP, and ApoB/ApoA-I ratio in women with iron deficiency anemia. Biol Trace Elem Res. 2016;169:34–40. doi:10.1007/s12011-015-0383-7.
  • Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol. 2007;78:487–494. doi:10.1111/j.1600-0609.2007.00842.x. PMID:17391310.
  • Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol. 2003;121:938–948. doi:10.1046/j.1365-2141.2003.04297.x. PMID:12786807.
  • Nielsen P, Kordes U, Fischer R, Engelhardt R, Janka GE. SQUID-biosusceptometry in iron overloaded patients with hematologic diseases. Klinische Pädiatrie. 2002;214:218–222. doi:10.1055/s-2002-33186.
  • Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971–977. doi:10.1046/j.1365-2141.2000.02298.x. PMID:11054091.
  • Chang TP, Rangan C. Iron poisoning: a literature-based review of epidemiology, diagnosis, and management. Pediatr Emerg Care. 2011;27:978–985. doi:10.1097/PEC.0b013e3182302604. PMID:21975503.
  • Anderson AC. Iron poisoning in children. Curr Opin Pediatr. 1994;6:289–294. doi:10.1097/00008480-199406000-00010. PMID:7914796.
  • Stoltzfus RJ, Dreyfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency Anemia (PDF). International Nutritional Anemia Consultative Group (INACG), World Health Organization (WHO), United Nations Childrens Fund (UNICEF). Washington, International Life Sciences Institute Press; 1998.
  • Allen LH. Iron supplements: scientific issues concerning efficacy and implications for research and programs. J Nutr. 2002;132:813S–819S. PMID:11925487.
  • Ben-Shachar D, Riederer P, Youdim MB. Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J Neurochem. 1991;57:1609–1614. doi:10.1111/j.1471-4159.1991.tb06358.x. PMID:1919577.
  • Ayton S, Lei P, Adlard PA, et al. Iron accumulation confers neurotoxicity to a vulnerable population of Nigral neurons: implications for Parkinson's disease. Mol Neurodegener. 2014;9:27. doi:10.1186/1750-1326-9-27. PMID:25011704.
  • Qin Y, Zhu W, Zhan C, et al. Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping. J Huazhong Univ.Sci Technolog Med Sci. 2011;31:578–585. doi:10.1007/s11596-011-0493-1.
  • Belaidi AA, Bush AI. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. J Neurochem. 2016;139(Suppl 1):179–197. doi:10.1111/jnc.13425. PMID:26545340.
  • Chen J, Marks E, Lai B, et al. Iron accumulates in Huntington's disease neurons: protection by deferoxamine. PLoS One 2013;8:e77023. doi:10.1371/journal.pone.0077023. PMID:24146952.
  • Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO. Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet 1998;351:490–493. doi:10.1016/S0140-6736(97)09272-6. PMID:9482441.
  • Rosenzweig PH, Volpe SL. Iron, thermoregulation, and metabolic rate. Crit Rev Food Sci Nutr. 1999;39:131–148. doi:10.1080/10408399908500491.
  • Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3:205–214. doi:10.1038/nrd1330. PMID:15031734.
  • Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med. 2002;32:833–840. doi:10.1016/S0891-5849(02)00772-4.
  • Hare D, Ayton S, Bush A, Lei P. A delicate balance: iron metabolism and diseases of the brain. Frontiers Aging Neurosci. 2013;5:34. doi:10.3389/fnagi.2013.00034.
  • Bayoumeu F, Subiran-Buisset C, Baka N, Legagneur H, Monnier-Barbarino P, Laxenaire M. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol. 2002;186:518–522. doi:10.1067/mob.2002.121894. PMID:11904617.
  • Fredriksson A, Schroder N, Eriksson P, Izquierdo I, Archer T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol. 1999;159:25–30. doi:10.1006/taap.1999.8711.
  • Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res Dev Brain Res. 2000;119:65–74. doi:10.1016/S0165-3806(99)00160-1. PMID:10648873.
  • Schröder N, Fredriksson A, Vianna M, Roesler R, Izquierdo I, Archer T. Memory deficits in adult rats following postnatal iron administration. Behav Brain Res. 2001;124:77–85. doi:10.1016/S0166-4328(01)00236-4.
  • Fredriksson A, Schröder N, Archer T. Neurobehavioural deficits following postnatal iron overload: i spontaneous motor activity. Neurotox Res. 2003;5:53–76. doi:10.1007/BF03033373.
  • Sobotka TJ, Whittaker P, Sobotka JM, et al. Neurobehavioral dysfunctions associated with dietary iron overload. Physiol Behav. 1996;59:213–219. doi:10.1016/0031-9384(95)02030-6.
  • Friel JK, Aziz K, Andrews WL, Harding SV, Courage ML, Adams RJ. A double-masked, randomized control trial of iron supplementation in early infancy in healthy term breast-fed infants. J Pediatr. 2003;143:582–586. doi:10.1067/S0022-3476(03)00301-9.
  • Robinson JM. Reactive oxygen species in phagocytic leukocytes. Histochem Cell Biol. 2008;130:281–297. doi:10.1007/s00418-008-0461-4. PMID:18597105.
  • Hajishengallis G, Chavakis T. Endogenous modulators of inflammatory cell recruitment. Trends Immunol. 2013;34:1–6. doi:10.1016/j.it.2012.08.003. PMID:22951309.
  • Crichton RR, Charloteaux-Wauters M. Iron transport and storage. Eur J Biochem. 1987;164:485–506. doi:10.1111/j.1432-1033.1987.tb11155.x. PMID:3032619.
  • Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature. J Clin Lab Anal. 1999;13:280–286. doi:10.1002/(SICI)1098-2825(1999)13:6<280::AID-JCLA5>3.0.CO;2-U.
  • Barnum-Huckins KM, Martinez AO, Rivera EV, et al. A comparison of the suppression of human transferrin synthesis by lead and lipopolysaccharide. Toxicology. 1997;118:11–22. doi:10.1016/S0300-483X(96)03586-X.
  • Zhao N, Enns C. Iron transport machinery of human cells: players and their interactions. Curr Topics Membr. 2012;69:67–93. doi:10.1016/B978-0-12-394390-3.00003-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.